Impact BioMedical, INC. Subsidiaries
Every subsidiary the company listed in Exhibit 21 of its annual reports, newest list first (1 lists). Names and jurisdictions are as filed.
- 2026-03-11: Subsidiary Entity Name; Jurisdiction Place of Incorporation.
- 2026-03-11: Subsidiary Impact Biolife Science, Inc.; Jurisdiction Nevada.
- 2026-03-11: Subsidiary Global BioMedical, Inc.; Jurisdiction Nevada.
- 2026-03-11: Subsidiary Global BioLife, Inc.; Jurisdiction Nevada.
| Annual report filed | Subsidiary | Jurisdiction |
|---|---|---|
| 2026-03-11 | Entity Name | Place of Incorporation |
| 2026-03-11 | Impact Biolife Science, Inc. | Nevada |
| 2026-03-11 | Global BioMedical, Inc. | Nevada |
| 2026-03-11 | Global BioLife, Inc. | Nevada |
| 2026-03-11 | Sweet Sense, Inc. | Nevada |
| 2026-03-11 | Happy Sugar, Inc. | Nevada |
| 2026-03-11 | Biolife Sugar, Inc. | Nevada |
| 2026-03-11 | DSS Biomedical International, Inc. | Nevada |
| 2026-03-11 | DSS Biolife International, Inc. | Nevada |
| 2026-03-11 | Global Sugar Solutions, Inc. | Nevada |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |